Journal
FRONTIERS IN MEDICINE
Volume 7, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2020.589553
Keywords
acute respiratory distress syndrome; acute lung injury; aging; immunosenescence; biomarkers
Categories
Funding
- Department for the Economy (Northern Ireland)
- Cystic Fibrosis Foundation [WELDON18G0]
- MaterHospital Young Philanthropist (YP) Trustees
- Medical Research Council [MR/T016760/1, MR/P022847/1]
- MRC [MC_G1002460, MR/T016760/1, MR/P022847/1] Funding Source: UKRI
Ask authors/readers for more resources
Acute respiratory distress syndrome (ARDS) is associated with increased morbidity and mortality in the elderly population (>= 65 years of age). Additionally, age is widely reported as a risk factor for the development of ARDS. However, the underlying pathophysiological mechanisms behind the increased risk of developing, and increased severity of, ARDS in the elderly population are not fully understood. This is compounded by the significant heterogeneity observed in patients with ARDS. With an aging population worldwide, a better understanding of these mechanisms could facilitate the development of therapies to improve outcomes in this population. In this review, the current clinical evidence of age as a risk factor and prognostic indicator in ARDS and the potential underlying mechanisms that may contribute to these factors are outlined. In addition, research on age-dependent treatment options and biomarkers, as well as future prospects for targeting these underlying mechanisms, are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available